{"id":6312,"date":"2026-09-01T16:50:42","date_gmt":"2026-09-01T08:50:42","guid":{"rendered":"https:\/\/hkeemall.com\/?post_type=product&#038;p=6312"},"modified":"2026-10-02T13:51:36","modified_gmt":"2026-10-02T05:51:36","slug":"1788252825","status":"publish","type":"product","link":"https:\/\/hkeemall.com\/en\/product\/1788252825\/","title":{"rendered":"(10% off when purchasing multiple boxes) Japanese Zepbound Obesity Treatment\u2014Weight-Loss Injections, Tirzepatide, Long-Acting GIP\/GLP-1 Receptor Agonist\u2014Lower Cholesterol, Promote Weight Loss"},"content":{"rendered":"<div class=\"mj-wrap\" style=\"max-width: 760px; margin: 0 auto; padding: 0 12px; color: #1c2328; font-family: 'PingFang TC','Hiragino Sans','Noto Sans TC','Microsoft JhengHei','Noto Sans JP',sans-serif; -webkit-font-smoothing: antialiased; line-height: 1.65; font-size: 15px; box-sizing: border-box; overflow-x: hidden;\">\n<style>\n@import url(\"https:\/\/fonts.googleapis.com\/css2?family=Noto+Sans+TC:wght@400;500;600;700&family=Noto+Serif+JP:wght@600;700&display=swap\");<br \/>.mj-wrap *,.mj-wrap *::before,.mj-wrap *::after{box-sizing:border-box}<br \/>.mj-title,.mj-keys,.mj-panel,.mj-comp,.mj-specs td,.mj-wrap p,.mj-wrap li{overflow-wrap:anywhere;word-break:break-word}<br \/>.mj-wrap table{width:100%;max-width:100%;border-collapse:collapse;font-size:13px;margin:10px 0;table-layout:fixed}<br \/>.mj-wrap th,.mj-wrap td{border:1px solid #e4dfd6;padding:8px 10px;vertical-align:top;text-align:left;white-space:normal;overflow-wrap:anywhere;word-break:break-word}<br \/>.mj-wrap th{background:#f3efe8;color:#1c2328;font-weight:600}<br \/>.mj-wrap img{max-width:100%;height:auto}<br \/>.mj-comp{margin:0 0 10px;padding:12px 14px;background:#fffcf8;border:1px solid #e4dfd6;border-radius:12px}<br \/>.mj-comp h4{margin:0 0 6px;font-size:14px;color:#1c2328}<br \/>.mj-comp p{margin:0 0 4px;font-size:13px;line-height:1.7;color:#5e6560}<br \/>@media (max-width:640px){<br \/>.mj-sheet-inner{padding:20px 14px 16px !important}<br \/>.mj-title{font-size:18px !important}<br \/>.mj-h{font-size:16px !important}<br \/>.mj-wrap table,.mj-wrap thead,.mj-wrap tbody,.mj-wrap tr,.mj-wrap .mj-specs,.mj-wrap .mj-specs tbody,.mj-wrap .mj-specs tr{display:block;width:100%;max-width:100%}<br \/>.mj-wrap th,.mj-wrap td,.mj-wrap .mj-specs th,.mj-wrap .mj-specs td{display:block;width:100%;max-width:100%;border-left:0;border-right:0}<br \/>.mj-wrap thead{display:none}<br \/>.mj-wrap .mj-specs th{padding:12px 12px 2px !important;background:transparent !important;border:0 !important;font-size:12px !important;color:#2c5a52 !important}<br \/>.mj-wrap .mj-specs td{padding:2px 12px 12px !important;border:0 !important;border-bottom:1px solid #e4dfd6 !important}<br \/>}<br \/><\/style>\n<article class=\"mj-sheet\" style=\"background: #fbf9f5; border: 1px solid #e4dfd6; border-radius: 24px; overflow: hidden; box-shadow: 0 1px 0 rgba(28,35,40,.04),0 18px 40px -24px rgba(28,35,40,.18);\">\n<div class=\"mj-bar\" style=\"height: 4px; background: #2c5a52;\"><\/div>\n<div><\/div>\n<div class=\"mj-kicker\" style=\"display: flex; align-items: center; justify-content: center; flex-wrap: wrap; gap: 8px; margin: 0 0 18px; color: #2c5a52; font-size: 11px; font-weight: 600; letter-spacing: .18em; text-align: center;\">Continuous GIP\/GLP-1 | Direct Shipping from Overseas (Direct Shipping from Japan)<\/div>\n<h2 class=\"mj-title\" style=\"font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 24px; font-weight: bold; line-height: 1.4; text-align: center; margin: 0 0 12px; color: #1c2328;\">Zepbound Subcutaneous Injection Ateos<\/h2>\n<h1 class=\"mj-title\" style=\"font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 24px; font-weight: bold; line-height: 1.4; text-align: center; margin: 0 0 12px; color: #1c2328;\"><span style=\"font-size: 16px;\">Zepbound ATEOS\u00ae <\/span><span style=\"text-align: center; font-size: 15px;\">Manjianle Slimming Injections<\/span><\/h1>\n<h2 class=\"mj-title\" style=\"font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 24px; font-weight: bold; line-height: 1.4; text-align: center; margin: 0 0 12px; color: #1c2328;\"><span style=\"font-size: 15px; font-weight: 600;\">2.5\/5\/7.5\/10\/12.5\/15 mg<\/span><\/h2>\n<p class=\"mj-keys\" style=\"margin: 0 auto 10px; max-width: 620px; text-align: center; color: #3f4a46; font-size: 14px; font-weight: 600; line-height: 1.7;\">2499422G7022_1_06 | 530471<br \/>\nSeptember 2026, 6th Edition \/ May 2026, 5th Edition (Changes to Efficacy and Dosage)<\/p>\n<p class=\"mj-keys\" style=\"margin: 0 auto 18px; max-width: 620px; text-align: center; color: #2c5a52; font-size: 14px; font-weight: 600; line-height: 1.7;\">Chilzepatide Injection | Obesity | Moderate-to-severe obstructive sleep apnea syndrome<\/p>\n<h2 style=\"text-align: center;\"><a href=\"https:\/\/hkeemall.com\/1787813600-2\/\">\u27a1\ufe0f Click to view the product instructions<\/a><\/h2>\n<figure class=\"mj-figure\" style=\"margin: 0 auto 24px; max-width: 100%; background: #fffcf8; border: 1px solid #e4dfd6; border-radius: 20px; padding: 12px;\"><a href=\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/09\/1-1.webp\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter\" style=\"width: 100%; height: auto; display: block;\" src=\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/09\/1-1.webp\" alt=\"Zepbound Slimming Injections\" width=\"500\" height=\"500\" \/><\/a><\/figure>\n<p style=\"font-size: 16px; font-weight: bold; color: #1c2328; margin: 0 0 12px; font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif;\">Admission, etc.<\/p>\n<div class=\"mj-specs-wrap\" style=\"margin: 0 0 28px; border: 1px solid #e4dfd6; border-radius: 16px; background: #fffcf8;\">\n<table class=\"mj-specs\">\n<tbody>\n<tr>\n<th>Classification<\/th>\n<td>872499 Long-acting GIP\/GLP-1 receptor agonist<\/td>\n<\/tr>\n<tr>\n<th>General Name<\/th>\n<td>Tirzepatide Injection (Tirzepatide)<\/td>\n<\/tr>\n<tr>\n<th>2.5mg<\/th>\n<td>YJ 2499422G7022 Approved 30600AMX00288<\/td>\n<\/tr>\n<tr>\n<th>5mg<\/th>\n<td>YJ 2499422G8029 Approved 30600AMX00289<\/td>\n<\/tr>\n<tr>\n<th>7.5mg<\/th>\n<td>YJ 2499422G9025 Approved 30600AMX00290<\/td>\n<\/tr>\n<tr>\n<th>10mg<\/th>\n<td>YJ 2499422P1024 Approved 30600AMX00291<\/td>\n<\/tr>\n<tr>\n<th>12.5mg<\/th>\n<td>YJ 2499422P2020 Approved 30600AMX00292<\/td>\n<\/tr>\n<tr>\n<th>15mg<\/th>\n<td>YJ 2499422P3027 Approved 30600AMX00293<\/td>\n<\/tr>\n<tr>\n<th>Sales Begin<\/th>\n<td>April 2025<\/td>\n<\/tr>\n<tr>\n<th>Storage Instructions \/ Expiration Date<\/th>\n<td>Store at 2\u20138\u00b0C \/ 24 months<\/td>\n<\/tr>\n<tr>\n<th>Regulatory Classification<\/th>\n<td>\u2013<\/td>\n<\/tr>\n<tr>\n<th>Manufacturing and Sales Yuan<\/th>\n<td>Eli Lilly Japan K.K.<br \/>\n5-1-28 Isogami-dori, Chuo Ward, Kobe City<\/td>\n<\/tr>\n<tr>\n<th>Sales Yuan<\/th>\n<td>Tanabe Pharma Co., Ltd.<br \/>\n3-2-10 Doshomachi, Chuo Ward, Osaka City<\/td>\n<\/tr>\n<tr>\n<th>Packaging<\/th>\n<td>Various sizes: 0.5 mL \u00d7 2 sets<\/td>\n<\/tr>\n<tr>\n<th>Shipping method<\/th>\n<td>Direct overseas shipping (Direct shipping from Japan)<\/td>\n<\/tr>\n<tr>\n<th>Preparation and shipping time<\/th>\n<td>Once payment and prescription eligibility have been verified, orders are typically shipped within 4 to 7 business days.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<section class=\"mj-sec\" style=\"margin: 0 0 22px;\">\n<h3 class=\"mj-h\" style=\"margin: 0 0 10px; padding: 0 0 8px; border-bottom: 1.5px solid #2c5a52; font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 17px; font-weight: bold; color: #1c2328;\">3. Composition and Properties<\/h3>\n<div class=\"mj-panel\" style=\"background: #f3efe8; border: 1px solid #e4dfd6; border-radius: 14px; padding: 16px 18px; color: #5e6560; font-size: 14px; line-height: 1.8;\">\n<p style=\"margin: 0 0 8px;\">A combination kit consisting of a pre-assembled syringe and an injector. Colorless to pale yellow to pale brown, clear or slightly opalescent liquid. pH 6.5\u20137.5. Osmolarity ratio of approximately 1.<\/p>\n<p style=\"margin: 0 0 8px;\">One package contains Chilizepatide 2.5, 5, 7.5, 10, 12.5, and 15 mg.<\/p>\n<p style=\"margin: 0 0 8px;\">Excipients (same for all strengths): disodium hydrogen phosphate heptahydrate 0.7 mg, sodium chloride 4.1 mg, hydrochloric acid as needed, sodium hydroxide as needed.<\/p>\n<p style=\"margin: 0;\">C<sub>225<\/sub>H<sub>348<\/sub>N<sub>48<\/sub>O<sub>68<\/sub>\u3000Molecular weight 4813.45; white powder. Positions 2 and 13 are 2-methyl-Ala; the C-terminus is an amidated Ser; 1,20-docosanedioic acid is linked to Lys at position 20 via a Glu and two 8-amino-3,6-dioxooctanoic acid linkers. A 39-amino acid synthetic peptide.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/09\/530471_2499422G7022_1_06_fig05.gif\" alt=\"Structural Formula\" \/><\/p>\n<\/div>\n<\/section>\n<section class=\"mj-sec\" style=\"margin: 0 0 22px;\">\n<h3 class=\"mj-h\" style=\"margin: 0 0 10px; padding: 0 0 8px; border-bottom: 1.5px solid #2c5a52; font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 17px; font-weight: bold; color: #1c2328;\">4.\uff0f5.\uff0f6.\uff0f7. Performance and Usage<\/h3>\n<div class=\"mj-panel\" style=\"background: #f3efe8; border: 1px solid #e4dfd6; border-radius: 14px; padding: 16px 18px; color: #5e6560; font-size: 14px; line-height: 1.8;\">\n<p style=\"margin: 0 0 8px;\"><strong>Obesity<\/strong>: Must have at least one of the following conditions\u2014hypertension, dyslipidemia, or impaired glucose tolerance (type 2 diabetes, impaired glucose tolerance, etc.)\u2014and for whom diet and exercise alone are insufficient, and who have a BMI of \u226527 along with at least two obesity-related health complications, or a BMI of \u226535.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>Moderate-to-severe OSA<\/strong>: Limited to patients with a BMI \u2265 27 and an AHI \u2265 15\/h.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>Dosage for Obesity:<\/strong>Start with 2.5 mg once weekly, then increase by 2.5 mg every 4 weeks until reaching 10 mg weekly. The dose may be reduced to 5 mg, or increased to 15 mg at intervals of \u22654 weeks.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>OSA dosage:<\/strong>Start with 2.5 mg once a week, increasing the dose by 2.5 mg every 4 weeks until reaching 15 mg per week; if intolerance occurs, adjust the dose within the range of 10\u201315 mg.<\/p>\n<p style=\"margin: 0;\">Administer on a fixed day of the week. If a dose is missed, administer it immediately provided at least 72 hours have elapsed since the previous dose and continue on the original day of the week; if less than 72 hours have elapsed, skip the dose. Changing the day of administration requires a minimum interval of 72 hours since the previous dose. In cases of gastrointestinal intolerance, consider reducing the dose or delaying the gradual increase. For patients with obesity, maintain a dose of 5 mg per week based on weight loss and tolerance.<\/p>\n<\/div>\n<\/section>\n<section class=\"mj-sec\" style=\"margin: 0 0 22px;\">\n<h3 class=\"mj-h\" style=\"margin: 0 0 10px; padding: 0 0 8px; border-bottom: 1.5px solid #2c5a52; font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 17px; font-weight: bold; color: #1c2328;\">18.\/16.\/17. Pharmacology, Pharmacokinetics, and Clinical Abstracts<\/h3>\n<div class=\"mj-panel\" style=\"background: #f3efe8; border: 1px solid #e4dfd6; border-radius: 14px; padding: 16px 18px; color: #5e6560; font-size: 14px; line-height: 1.8;\">\n<p style=\"margin: 0 0 8px;\">GIP and GLP-1 in the central nervous system regulate appetite, while GIP in adipocytes promotes lipid metabolism. The C20 fatty acid side chain binds to albumin, with a half-life (t\u00bd) of approximately 5\u20136 days and an absolute bioavailability of approximately 80%. Protein binding is 99.06%. AUC values are similar in the abdomen, upper arm, and thigh. Trace amounts of 4.6\u20137.2 ng\/mL have been detected in breast milk.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/09\/530471_2499422G7022_1_06_fig01.gif\" alt=\"Plasma concentration\" \/><\/p>\n<p style=\"margin: 8px 0;\">Domestic obesity trial: 72-week weight change: 10 mg \u221218.41 TP3T, 15 mg \u221222.61 TP3T, placebo \u22121.81 TP3T; weight loss of 94.91 TP3T among participants with a baseline weight of \u226551 TP3T \/ 96.91 TP3T vs. 21.21 TP3T. In an international prediabetic population, the hazard ratio (HR) for developing type 2 diabetes at 176 weeks was 0.06.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/09\/530471_2499422G7022_1_06_fig02.gif\" alt=\"Onset of Diabetes\" \/><\/p>\n<p style=\"margin: 8px 0;\">OSA 52-week AHI: Without PAP, \u221228.1 vs. \u22124.2\/h; with PAP, \u221229.4 vs. \u22127.9\/h.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/09\/530471_2499422G7022_1_06_fig03.gif\" alt=\"AHI Fig. 03\" \/><br \/>\n<img decoding=\"async\" src=\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/09\/530471_2499422G7022_1_06_fig04.gif\" alt=\"AHI Fig. 04\" \/><\/p>\n<\/div>\n<\/section>\n<section class=\"mj-sec\" style=\"margin: 0 0 22px;\">\n<h3 class=\"mj-h mj-h-alert\" style=\"margin: 0 0 10px; padding: 0 0 8px; border-bottom: 1.5px solid #7a2e2e; font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 17px; font-weight: bold; color: #7a2e2e;\">2, 8, 9, 10, 11, 14, 15, 20. Please note<\/h3>\n<div class=\"mj-panel mj-panel-alert\" style=\"background: #f7efe9; border: 1px solid #e4cfc6; border-radius: 14px; padding: 16px 18px; color: #6b3a34; font-size: 14px; line-height: 1.8;\">\n<p style=\"margin: 0 0 8px;\"><strong>2. Contraindications:<\/strong>Allergy to any ingredient; diabetic ketoacidosis, coma\/pre-coma, type 1 diabetes; type 2 diabetes complicated by severe infections, surgery, or other emergencies. Do not administer to pregnant women (9.5).<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>8.<\/strong> Continue with diet and exercise. Effects may persist after discontinuation. Discontinue use and seek medical attention if early symptoms of acute pancreatitis occur. Diarrhea and vomiting may lead to dehydration and acute kidney injury. Monitor for signs of thyroid dysfunction, gallstones\/cholecystitis, and decreased blood pressure. Self-injection requires training and proper disposal of used needles. This is not an insulin replacement therapy. Inform patients about hypoglycemia. Do not use in combination with MANGALO or other GLP-1 agonists. Safety and efficacy of concomitant use with DPP-4 inhibitors have not been established. For obesity, discontinue if no improvement is seen after 3\u20134 months. For OSA, assess whether to use CPAP concurrently; do not continue treatment indefinitely if AHI does not improve.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>9.<\/strong> Severe gastric paralysis, history of pancreatitis, predisposition to hypoglycemia, retinal disorders such as proliferative retinopathy or macular edema, history of abdominal surgery or intestinal obstruction, general anesthesia or deep sedation (reports of aspiration). Women of childbearing potential should use contraception for 1 month after receiving the middle and final doses. The use of this medication during breastfeeding requires careful consideration. Not tested in children. Use with caution in the elderly.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>10.2:<\/strong>For diabetes medications (especially sulfonylureas, rapid-acting secretagogues, and insulin), monitor for hypoglycemia and consider reducing the dose; the effectiveness of oral contraceptives may be reduced at the start of treatment or during the initial dose-escalation phase; exercise caution with narrow-therapeutic-range oral medications such as warfarin.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>11.1:<\/strong>Hypoglycemia (frequency unknown); acute pancreatitis (&lt;0.11 TP3T); cholecystitis, cholangitis, cholestatic jaundice; allergic reactions, angioedema; ileus.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>11.2 \u22655%:<\/strong>Nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, loss of appetite, and reactions at the injection site.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>14.<\/strong> Before use, check the syringe and the medication. Administer by subcutaneous injection in the abdomen, thigh, or upper arm, changing the injection site within the same area each time; do not administer by intravenous or intramuscular injection.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong>15.<\/strong> Observational studies suggest a possible increased risk of NAION. Phase III anti-drug antibody levels were approximately 65.51 TP3T. An increase in thyroid C-cell tumors was observed in rats; safety has not been established in patients with a family history of medullary thyroid carcinoma or MEN2.<\/p>\n<p style=\"margin: 0;\"><strong>20.<\/strong> To prevent freezing, store at 2\u20138\u00b0C away from light; do not use if frozen. When stored at room temperature (\u226437\u00b0C) in the original packaging, use within 21 days.<\/p>\n<\/div>\n<\/section>\n<section class=\"mj-sec\" style=\"margin: 0 0 22px;\">\n<h3 class=\"mj-h\" style=\"margin: 0 0 10px; padding: 0 0 8px; border-bottom: 1.5px solid #2c5a52; font-family: 'Noto Serif JP','Songti TC','PMingLiU',serif; font-size: 17px; font-weight: bold; color: #1c2328;\">21\u201326. Other Official Information<\/h3>\n<div class=\"mj-panel\" style=\"background: #f3efe8; border: 1px solid #e4dfd6; border-radius: 14px; padding: 16px 18px; color: #5e6560; font-size: 14px; line-height: 1.8;\">\n<p style=\"margin: 0 0 8px;\"><strong style=\"color: #1c2328;\">21.<\/strong> A drug risk management plan must be developed and implemented.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong style=\"color: #1c2328;\">22.<\/strong> Each specification: 0.5 mL \u00d7 2 sets.<\/p>\n<p style=\"margin: 0 0 8px;\"><strong style=\"color: #1c2328;\">24.<\/strong> Eli Lilly Japan\u2014Medical Information Inquiries: TEL 0120-360-605 medical.lilly.com\/jp<br \/>\nTanabe Pharma Medication Consultation Center TEL 0120-753-280<\/p>\n<p style=\"margin: 0 0 8px;\"><strong style=\"color: #1c2328;\">25.<\/strong> Under the \u201cObesity\u201d category, only \u201chypertension, dyslipidemia, or type 2 diabetes\u201d are eligible for insurance coverage. (Insurance and Medical Affairs Notice No. 0518-2: May 18, Reiwa 8)<\/p>\n<p style=\"margin: 0;\"><strong style=\"color: #1c2328;\">26.<\/strong> Manufacturer: Eli Lilly Japan K.K. \/ Distributor: Tanabe Pharma Co., Ltd. \u00ae Registered Trademark<\/p>\n<\/div>\n<\/section>\n<div class=\"mj-foot\" style=\"margin: 8px 0 0; padding: 18px 8px 4px; border-top: 1px solid #e4dfd6; text-align: center; color: #7a2e2e; font-size: 13px; line-height: 1.7;\">\u203b This page was translated by Hkeemall based on PMDA Package Insert 2499422G7022_1_06 (6th Edition, September 2026) and is not a substitute for a doctor\u2019s prescription or the original Japanese version.<br \/>\n<a style=\"color: #7a2e2e; font-weight: bold; text-decoration: underline;\" href=\"https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/530471_2499422G7022_1_06#DOC_12\" target=\"_blank\" rel=\"noreferrer noopener\">Enter \"Zepbound\" in the PMDA's \"Package Insert Information\" field to search for the original version.<\/a><\/div>\n<\/article>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Long-Acting GIP\/GLP-1 | Direct Shipping from Overseas (Direct from Japan) Zepbound Subcutaneous Injection ATEOS\u00ae<\/p>\n<div class=\"klb-readmore post-buttons\"><a class=\"button rounded primary\" href=\"https:\/\/hkeemall.com\/en\/product\/1788252825\/\">Read More <i class=\"klbth-icon-right-arrow\"><\/i><\/a><\/div>","protected":false},"featured_media":7008,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[226],"product_cat":[78,77,39,23],"product_tag":[207],"class_list":["post-6312","product","type-product","status-publish","has-post-thumbnail","product_brand-eli-lilly","product_cat-78","product_cat-77","product_cat-medication","product_cat-allergies","product_tag-eli-lilly","first","instock","sale","featured","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"_links":{"self":[{"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/product\/6312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/comments?post=6312"}],"version-history":[{"count":41,"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/product\/6312\/revisions"}],"predecessor-version":[{"id":8271,"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/product\/6312\/revisions\/8271"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/media\/7008"}],"wp:attachment":[{"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/media?parent=6312"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/product_brand?post=6312"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/product_cat?post=6312"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/hkeemall.com\/en\/wp-json\/wp\/v2\/product_tag?post=6312"}],"curies":[{"name":"Well played","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}